Literature DB >> 19414481

Dealing with at-risk populations in radiological/nuclear emergencies.

Diana Wilkinson1.   

Abstract

In a mass casualty event, there will be at-risk populations that will require unique triage, treatment and consequence management to minimise immediate and long-term health effects. This statement is particularly true for radiological/nuclear (R/N) disasters where individuals exhibit a broad range of physiological responses to radiation exposure. For example, immunocompromised individuals will experience more detrimental radiation health effects; however, it is not always possible to definitively identify these individuals at the time of triage. Immediate and long-term consequence management for these individuals may require unique and potentially limited resources. Thus, at the time of an R/N event, it is crucial to assist community planners by: (a) rapidly identifying at-risk individuals who may have been exposed; (b) determining the dose and individual-specific health risks associated with radiation exposure; (c) identifying additional resources needed to deal with unique, population-specific requirements; and (d) developing treatment strategies in keeping with the rules of 'supply and demand'. A comprehensive approach to identifying issues relevant to the R/N emergency preparedness for dealing with at-risk populations will be discussed with the aim of defining future research objectives.

Mesh:

Year:  2009        PMID: 19414481     DOI: 10.1093/rpd/ncp070

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide.

Authors:  Evagelia C Laiakis; Daniel R Hyduke; Albert J Fornace
Journal:  Radiat Res       Date:  2011-11-30       Impact factor: 2.841

2.  Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation.

Authors:  Evagelia C Laiakis; Tytus D Mak; Sebastien Anizan; Sally A Amundson; Christopher A Barker; Suzanne L Wolden; David J Brenner; Albert J Fornace
Journal:  Radiat Res       Date:  2014-03-27       Impact factor: 2.841

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.